Skip to main content

Jordi Lozano Torres

Institutions of which they are part

Main researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Jordi Lozano Torres

Institutions of which they are part

Main researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

Personal Investigador para Grupo Cardiovascular

IP: Ignacio Ferreira González
Collaborators: Alba Santos Ortega, José Antonio Barrabés Riu, Maria Vidal Burdeus, Jose Fernando Rodríguez Palomares, Laura Gutierrez García-Moreno, Antonia Sambola Ayala, Nuria Rivas Gandara, Jordi Perez Rodon, Angeles Rojas Lopez, Antonio Rodríguez Sinovas, Artur Evangelista Masip, Teresa González Alujas, Begoña Benito Villabriga, Gisela Teixido Tura, Antonia Pijuan Domenech, Enric Domingo Ribas, Victor Gonzalez Fernandez, Santiago Aguade Bruix, Guillem Casas Masnou, David Aluja Gonzalez, Bernat Serra Creus, Vicente Serra García, Gerard Marti Aguasca, Neus Bellera Gotarda, Aitor Uribarri Gonzalez, Imanol Otaegui Irurueta, Jordi Bañeras Rius, Bruno García del Blanco, Ruperto Olivero Soldevila, Elisabet Miro Casas, Marisol Ruiz Meana, Mireia Andres Villarreal, Jordi Lozano Torres, Ana Belén Méndez Fernández, Berta Miranda Barrio, Gerard Oristrell Santamaria, Pau Rello Sabaté, Toni Soriano Colomé, Jaume Francisco Pascual, Aleix Olivella San emeterio, Sara Delgado Tomás, Aroa Ruiz Muñoz, Javier Inserte Igual, Mª Ángeles Carmona Ramírez, Javier Limeres Freire, Irene Buera Surribas, Ruben Fernández Galera, Raul Aguilar Lopez, Alvaro Calabuig Goena, Lydia Dux-Santoy Hurtado, Laura Galián Gay, Laura Dos Subirá, Maria Nazarena Pizzi, Bou Teen, Diana, Filipa Xavier De Carvalho Negrao Valente, Andrea Guala
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00758
Duration: 01/01/2022 - 30/06/2025

Impact of an exercise-based rehabilitation program in patients with Marfan syndrome on physical, psychological and cardiovascular health

IP: Gisela Teixido Tura
Collaborators: Laura Gutierrez García-Moreno, Jordi Lozano Torres, Alba Gómez Garrido, Lydia Dux-Santoy Hurtado, PATRICIA LAUNOIS OBREGÓN, Filipa Xavier De Carvalho Negrao Valente, Raul Aguilar Lopez, Clara Badia Molins
Funding agency: Instituto de Salud Carlos III
Funding: 45375
Reference: PI21/00448
Duration: 01/01/2022 - 31/12/2024

Rehab+

IP: Jordi Lozano Torres
Collaborators: Irene Montllor Ramoneda
Funding agency: EIT- European Institute of Innovation & Technolog
Funding: 55865.85
Reference: REHAB+_EIT HEALTH2020
Duration: 01/01/2021 - 31/12/2022

Evaluación de la efectividad del seguimiento mediante app de pacientes atendidos en una Consulta de Rehabilitación y Control de Riesgo Cardiovascular

IP: Ignacio Ferreira González
Collaborators: Aida Ribera Sole, Jordi Lozano Torres, Gerard Oristrell Santamaria, Javier Limeres Freire
Funding agency: Fundación Merck Salud
Funding: 10000
Reference: MERCK2019/IFERREIRA
Duration: 02/12/2019 - 02/12/2021

Related news

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

Related professionals

Alba Torija Recasens

Alba Torija Recasens

Predoctoral researcher
Nephrology and kidney transplantation
Read more
Carmina Castellano Tejedor

Carmina Castellano Tejedor

Senior researcher
Research on Aging, Frailty and Transitions in Barcelona
Read more
Concepció Jacobs Cachá

Concepció Jacobs Cachá

Main researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Xavier Serra Ruiz

Xavier Serra Ruiz

Research technician
Physiology and Pathophysiology of the Digestive Tract
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.